Sign up Canada
Proactive Investors - Run By Investors For Investors

PreveCeutical Medical receives second Aurora cannabis shipment

The pot materials will be used in PreveCeutical's soluble gel (Sol-gel) drug delivery research...
PreveCeutical Medical receives second Aurora cannabis shipment
The materials from the shipment will be used in PreveCeutical's soluble gel (Sol-gel) drug delivery research

PreveCeutical Medical Inc (CSE:PREV, OTCQB:PRVCF) has received the second shipment of dried cannabis materials from major Aurora Cannabis, it told investors.

The pot materials will be used in PreveCeutical's soluble gel (Sol-gel) drug delivery research.

As revealed in March, the company, in a major milestone, had received the key permits to allow this material to be imported into Australia by the  cannabis major.

It is being used for the group's research led by Preveceutical's chief research officer Dr Harendra Parekh at the University of Queensland.

Preveceutical aims to develop therapies for relief from a range of symptoms, including pain, inflammation, seizures and neurological disorders.

The advantages of Sol-gels over conventional liquid nasal sprays include reduced dosage requirements, and reduced irritation and other negative side effects.

Shares were unchanged at C$0.29.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Related Articles

Drug discovery
April 04 2018
In the group’s 2017 results statement at the end of March, Ray Barlow - who took over as CEO on 6 April 2017 - commented: “We are now focused on the right activities"
hepatitisC.jpg
January 18 2018
Regulatory sign-off fires starting pistol on the commercial launch in Europe, Africa, EU Medical Devices Directive awarded CE IVD certification, molecular diagnostics, Europe, Africa, Sysmex
Skin beauty
April 19 2018
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use